IRCT20200621047859N3招募中1 期
Phase I/II Clinical Trial (Safety and feasibility) using ex-vivo expanded Haploidentical donor-derived (Natural Killer Cell)-NK Cells against advanced refractory/relapsed Acute Myeloid Leukemia (AML)
Motamed Cancer Institute0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 70 years（—）
- 性别
- All
入选标准
- •1- Age 18 to 70 years
- •2. Drug-resistant AML patients with no response to 2 treatments line or recurrent cases that can not be candidates for standard therapies or bone marrow transplants
- •3- The toxicity of chemotherapy regimens ( such as severe cytopenia) should be assigned and it would be checked as a regimen with no significant side effects.
- •4- PS=2[Performance Status (PS)]
- •5- The results of these tests should be available:• [glomerular filtration rate (GFR)] GFR=60 or CR=2 mg / dl• ALT <2.5XULN / Bid=2• O2Sat> 92% in room air• Cardiac classification status (III> NHC) or [ejection fraction]EF> 50%• Negative pregnancy test• Negative HIV testing
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
Clinical Trial Phase I / II to evaluate the safety and efficacy of the infusion of cells transduced with a therapeutic lentiviral vector for patients with Fanconi Anemia Subtype A.EUCTR2011-006100-12-ESFUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSITARIO NIÑO JESUS5
尚未招募
1 期
CIGB-Mambisa/Abdala in convalescentsCOVID-19 ConvalescenceCOVID-19SARS-CoV2Coronavirus InfectionsSARS VirusCoronaviridae InfectionsBetacoronavirusRPCEC00000382Center for Genetic Engineering and Biotechnology (CIGB)120
进行中（未招募）
1 期
Clinical trial evaluating the safety, neutralizing capacity and the lowest effective dose for antivenom treatment of multiple Africanized bees stings Apis melliferaRBR-3fthf8Faculdade de Medicina de Botucatu
招募中
1 期
Phase I/IIa trial of Ga-68 PSMA-11 produced on the MPS200 PSMA-Ga automated synthesizerJPRN-jRCT2022230014Shiga Tohru9
进行中（未招募）
1 期
Safety assessment and dose of fibrin sealant derived from snake venom in the treatment of wounds.RBR-9mbdj3Faculdade de Medicina de Botucatu - Unesp